M Ventures — 2024 Investments
6 investments dated 2024 · listed companies and verified rows first · show all
Abselion develops measurement tools and a platform combining hardware, purpose-built assay formats, and software for biological measurements such as protein quantification.
BiotechDeep TechHardwareMedical DevicesCambridge, GB
Dr Ruizhi Wang(CEO)
Co-investorsCambridge Angels groupBusiness Growth FundR42 GroupThe Engine VenturesUniversity of Cambridge EnterpriseUntitled Ventures
Enara Bio discovers and validates Dark Antigens from non-coding genomic regions to identify novel cancer targets, and develops first-in-class bispecific T-cell engagers against these targets through its EnTiCE platform.
BiotechDeep TechMedical Devices
George Kassiotis(Co-founder)Drew Pardoll(Co-founder)Houman Ashrafian(Co-founder)inKevin Pojasekin
Co-investorsRA CapitalSamsara BioCapitalSV Health InvestorsPfizer VenturesDementia Discovery FundPfizer Venture Investments
iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.
BiotechDeep TechHealthtechMedical Devices
Catherine Pickering(Co-Founder & CEO)inLars van der Veen(Co-Founder & CSO)inMichael Lahn(CMO)inElizabeth Holt(CBO)inSteven Sciuto(CFO)inMichelle Tsai(COO)in
Co-investorsInkef3B Future Health FundVI PartnersXGEN VentureJohnson & Johnson Innovation – JJDC
IonKraft, a spin-off from the Institute of Plastics Processing (IKV) at RWTH Aachen University, develops a barrier coating technology for mono-material plastic containers that provides the barrier and chemical resistance of multi-layer packaging while remaining fully recyclable.
Advanced ManufacturingCircular EconomyCleantechNew MaterialsAachen, DE
Bene(Co-Founder & Managing Director)inMonty(Co-Founder & Managing Director)
Co-investorsSeed Fonds AachenTechVision FondsTechVision Fund
Co-investorsIn-Q-TelTGVPTransLink Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Disco Pharmaceuticals
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






















